ACTB |
Actin, b |
AHA |
l-azidohomoalanine |
AKT1 |
Thymoma viral proto-oncogene homolog 1 |
ATG |
Autophagy-related |
BAX |
BCL2-associated X protein |
BCL2 |
B-cell CLL/lymphoma 2 |
BECN1 |
Beclin 1 |
BPTES |
Bis-2-(5-phenylacetamido-1, 3, 4-thiadiazol-2-yl)ethylsulfide |
CAM |
Cell-aged medium |
CASP3 |
Caspase 3 |
CCM |
Cell-conditioned medium |
CDK4 |
Cyclin dependent kinase 4 |
CYCS |
Cytochrome c |
GABARAP |
GABA(A) receptor-associated protein |
GLS |
Glutaminase |
HK |
Hexokinase |
MAP1LC3B |
Microtubule-associated protein 1 light chain 3 b |
MAPK |
Mitogen-activated protein kinases |
IGF |
Insulin growth factor |
JC-1 |
5,5′,6,6′-tetrachloro-1,1′3,3′-tetrathylbenzimidazolyl-carbocyanine iodide |
mTOR |
Mechanistic target of rapamycin |
mTORC |
mTOR complex |
PHB |
Prohibitin |
PI3K |
Phosphatidylinositol 3-kinase; |
NACT |
Neoadjuvant chemotherapy |
PRKAA2 |
Protein kinase AMP-activated |
RPS6KA1 |
Ribosomal protein S6 kinase A1 |
SQSTM1 |
Sequestosome 1 |
T2D |
Type 2 diabetes |
TCA |
Tricarboxylic acid cycle |
TEM |
Transmission electron microscopy |